Legend Biotech Corporation - American Depositary Shares (LEGN)

Legend Biotech Corp is a biotechnology company focused on the development and commercialization of innovative cell therapies for the treatment of cancer and other serious diseases

The company leverages its proprietary technologies to create advanced cellular therapies, particularly in the realm of engineered T cell therapy, aiming to harness the body's immune system to target and eliminate malignant cells. Through rigorous research and clinical trials, Legend Biotech is committed to addressing unmet medical needs and enhancing patient outcomes in the field of oncology.